---
document_datetime: 2023-09-21 17:51:39
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vizarsin-epar-all-authorised-presentations_en.pdf
document_name: vizarsin-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.8530477
conversion_datetime: 2025-12-25 00:31:13.693826
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging            | Pack size                  |
|------------------|-------------------|------------|-----------------------|---------------------------|--------------------------------|----------------------------|
| EU/1/09/551/001  | Vizarsin          | 25 mg      | Film-coated tablet    | Oral use                  | blister (PVC/Alu)              | 1 tablet                   |
| EU/1/09/551/002  | Vizarsin          | 25 mg      | Film-coated tablet    | Oral use                  | blister (PVC/Alu)              | 4 x 1 tablets (unit dose)  |
| EU/1/09/551/003  | Vizarsin          | 25 mg      | Film-coated tablet    | Oral use                  | blister (PVC/Alu)              | 8 x 1 tablets (unit dose)  |
| EU/1/09/551/004  | Vizarsin          | 25 mg      | Film-coated tablet    | Oral use                  | blister (PVC/Alu)              | 12 x 1 tablets (unit dose) |
| EU/1/09/551/005  | Vizarsin          | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/Alu)              | 1 tablet                   |
| EU/1/09/551/006  | Vizarsin          | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/Alu)              | 4 x 1 tablets (unit dose)  |
| EU/1/09/551/007  | Vizarsin          | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/Alu)              | 8 x 1 tablets (unit dose)  |
| EU/1/09/551/008  | Vizarsin          | 50 mg      | Film-coated tablet    | Oral use                  | blister (PVC/Alu)              | 12 x 1 tablets (unit dose) |
| EU/1/09/551/009  | Vizarsin          | 100 mg     | Film-coated tablet    | Oral use                  | blister (PVC/Alu)              | 1 tablet                   |
| EU/1/09/551/010  | Vizarsin          | 100 mg     | Film-coated tablet    | Oral use                  | blister (PVC/Alu)              | 4 x 1 tablets (unit dose)  |
| EU/1/09/551/011  | Vizarsin          | 100 mg     | Film-coated tablet    | Oral use                  | blister (PVC/Alu)              | 8 x 1 tablets (unit dose)  |
| EU/1/09/551/012  | Vizarsin          | 100 mg     | Film-coated tablet    | Oral use                  | blister (PVC/Alu)              | 12 x 1 tablets (unit dose) |
| EU/1/09/551/013  | Vizarsin          | 25 mg      | Orodispersible tablet | Oral use                  | blister (OPA/Alu/PVC//PET/Alu) | 1 tablet                   |
| EU/1/09/551/014  | Vizarsin          | 25 mg      | Orodispersible tablet | Oral use                  | blister (OPA/Alu/PVC//PET/Alu) | 2 x 1 tablets (unit dose)  |
| EU/1/09/551/015  | Vizarsin          | 25 mg      | Orodispersible tablet | Oral use                  | blister (OPA/Alu/PVC//PET/Alu) | 4 x 1 tablets (unit dose)  |
| EU/1/09/551/016  | Vizarsin          | 25 mg      | Orodispersible tablet | Oral use                  | blister (OPA/Alu/PVC//PET/Alu) | 8 x 1 tablets (unit dose)  |

<div style=\"page-break-after: always\"></div>

EU/1/09/551/017

EU/1/09/551/018

EU/1/09/551/019

EU/1/09/551/020

EU/1/09/551/021

EU/1/09/551/022

EU/1/09/551/023

EU/1/09/551/024

EU/1/09/551/025

EU/1/09/551/026

EU/1/09/551/027

EU/1/09/551/028

EU/1/09/551/029

Vizarsin

Vizarsin

Vizarsin

Vizarsin

Vizarsin

Vizarsin

Vizarsin

Vizarsin

Vizarsin

Vizarsin

Vizarsin

Vizarsin

Vizarsin

25 mg

50 mg

50 mg

50 mg

50 mg

50 mg

100 mg

100 mg

100 mg

100 mg

100 mg

50 mg

100 mg

Orodispersible tablet

Orodispersible tablet

Orodispersible tablet

Orodispersible tablet

Orodispersible tablet

Orodispersible tablet

Orodispersible tablet

Orodispersible tablet

Orodispersible tablet

Orodispersible tablet

Orodispersible tablet

Orodispersible tablet

Orodispersible tablet

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use

Oral use blister

(OPA/Alu/PVC//PET/Alu)

blister

(OPA/Alu/PVC//PET/Alu)

blister

(OPA/Alu/PVC//PET/Alu)

blister

(OPA/Alu/PVC//PET/Alu)

blister

(OPA/Alu/PVC//PET/Alu)

blister

(OPA/Alu/PVC//PET/Alu)

blister

(OPA/Alu/PVC//PET/Alu)

blister

(OPA/Alu/PVC//PET/Alu)

blister

(OPA/Alu/PVC//PET/Alu)

blister

(OPA/Alu/PVC//PET/Alu)

blister

(OPA/Alu/PVC//PET/Alu)

blister

(OPA/Alu/PVC//PET/Alu)

blister

(OPA/Alu/PVC//PET/Alu)

12 x 1 tablets (unit dose)

1 tablet

2 x 1 tablets (unit dose)

4 x 1 tablets (unit dose)

8 x 1 tablets (unit dose)

12 x 1 tablets (unit dose)

1 tablet

2 x 1 tablets (unit dose)

4 x 1 tablets (unit dose)

8 x 1 tablets (unit dose)

12 x 1 tablets (unit dose)

24 x 1 tablets (unit dose)

24 x 1 tablets (unit dose)